Affinity analysis of differentially expressed genes in hepatocytes expressing HCV core genotype 1b or 3a

[1]  X. Causse,et al.  Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. , 1991, Gastroenterology.

[2]  O. Weiland,et al.  Serum HCV RNA levels in patients with chronic hepatitis C given a second course of interferon alpha-2b treatment after relapse following initial treatment. , 1993, Scandinavian journal of infectious diseases.

[3]  C. Rice,et al.  Expression and identification of hepatitis C virus polyprotein cleavage products , 1993, Journal of virology.

[4]  J. Pawlotsky,et al.  Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. , 1995, The Journal of infectious diseases.

[5]  K. Meyer,et al.  Suppression of apoptotic cell death by hepatitis C virus core protein. , 1996, Virology.

[6]  K Koike,et al.  Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. , 1997, The Journal of general virology.

[7]  Dumoulin,et al.  Hepatitis C virus core protein does not inhibit apoptosis in human hepatoma cells , 1999, European journal of clinical investigation.

[8]  M. Honda,et al.  Hepatitis C virus core protein induces apoptosis and impairs cell‐cycle regulation in stably transformed chinese hamster ovary cells , 2000, Hepatology.

[9]  Huang Yuan-zhu.  Preliminary analysis of gene expression profiles in human myocardium of atrial septal defect by cDNA microarray , 2003 .

[10]  M. Miyazaki,et al.  Stearoyl-CoA Desaturase 1 Gene Expression Is Necessary for Fructose-mediated Induction of Lipogenic Gene Expression by Sterol Regulatory Element-binding Protein-1c-dependent and -independent Mechanisms* , 2004, Journal of Biological Chemistry.

[11]  T. Kawaguchi,et al.  Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. , 2004, The American journal of pathology.

[12]  V. Pazienza,et al.  An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation. , 2005, Journal of hepatology.

[13]  Colin W Shepard,et al.  Global epidemiology of hepatitis C virus infection. , 2005, The Lancet. Infectious diseases.

[14]  D. Lavillette,et al.  Characterization of host‐range and cell entry properties of the major genotypes and subtypes of hepatitis C virus , 2005, Hepatology.

[15]  Alan Bundy,et al.  Constructing Induction Rules for Deductive Synthesis Proofs , 2006, CLASE.

[16]  John S. Satterlee,et al.  An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis , 2006, Nature.

[17]  J. Dou,et al.  Preliminary analysis of gene expression profiles in HepG2 cell line induced by different genotype core proteins of HCV. , 2006, Cellular & molecular immunology.

[18]  Sutapa Banerjee,et al.  Hepatitis C Virus Core Protein Upregulates Serine Phosphorylation of Insulin Receptor Substrate-1 and Impairs the Downstream Akt/Protein Kinase B Signaling Pathway for Insulin Resistance , 2007, Journal of Virology.

[19]  L. Guarente,et al.  SIRT1 deacetylates and positively regulates the nuclear receptor LXR. , 2007, Molecular cell.

[20]  B. Giraudeau,et al.  The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model , 2007, Gut.

[21]  Min Jung Park,et al.  HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma. , 2007, Biochemical and biophysical research communications.

[22]  V. Pazienza,et al.  The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype‐specific mechanisms , 2007, Hepatology.

[23]  Y. Karino,et al.  Treatment of chronic non-A, non-B hepatitis with interferon , 1991, Gastroenterologia Japonica.

[24]  David Warde-Farley,et al.  GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function , 2008, Genome Biology.

[25]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[26]  P. Pfluger,et al.  Sirt1 protects against high-fat diet-induced metabolic damage , 2008, Proceedings of the National Academy of Sciences.

[27]  V. Pazienza,et al.  Gene expression profile of Huh‐7 cells expressing hepatitis C virus genotype 1b or 3a core proteins , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[28]  Yves Moreau,et al.  Integrating Computational Biology and Forward Genetics in Drosophila , 2009, PLoS genetics.

[29]  L. Hood,et al.  Systems medicine: the future of medical genomics and healthcare , 2009, Genome Medicine.

[30]  Paolo Ballarini,et al.  Studying Irreversible Transitions in a Model of Cell Cycle Regulation , 2009, PASM@EPEW.

[31]  Qing Xu,et al.  Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. , 2009, Cell metabolism.

[32]  Jing Chen,et al.  ToppGene Suite for gene list enrichment analysis and candidate gene prioritization , 2009, Nucleic Acids Res..

[33]  Xiaoling Xu,et al.  Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. , 2010, Cell metabolism.

[34]  T. Shioda,et al.  MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis , 2010, Science.

[35]  I. Gérin,et al.  Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation* , 2010, The Journal of Biological Chemistry.

[36]  Ferenc Jordán,et al.  Estimating the divisibility of complex biological networks by sparseness indices , 2010, Briefings Bioinform..

[37]  T. Veenstra,et al.  SIRT1 Deacetylates and Inhibits SREBP-1C Activity in Regulation of Hepatic Lipid Metabolism* , 2010, The Journal of Biological Chemistry.

[38]  K. Moore,et al.  miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling , 2011, Proceedings of the National Academy of Sciences.

[39]  V. Pazienza,et al.  Impact of HCV genetic differences on pathobiology of disease , 2011, Expert review of anti-infective therapy.

[40]  Teresa Balsamo,et al.  Hypermethylated levels of E-cadherin promoter in Huh-7 cells expressing the HCV core protein. , 2011, Virus research.

[41]  Tommaso Mazza,et al.  Mirna Expression Profiles Identify Drivers in Colorectal and Pancreatic Cancers , 2012, PloS one.

[42]  Rosita Guido,et al.  The Relevance of Topology in Parallel Simulation of Biological Networks , 2012, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[43]  M. Vinciguerra,et al.  DNA Methyltransferases 1 and 3b Expression in Huh-7 Cells Expressing HCV Core Protein of Different Genotypes , 2012, Digestive Diseases and Sciences.

[44]  Angela Re,et al.  AURA: Atlas of UTR Regulatory Activity , 2012, Bioinform..

[45]  M. Vinciguerra,et al.  Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD). , 2013, Current pharmaceutical design.